Let’s build the future of medicine - together.
Join Enveda as a Senior Director, Translational Immunology and Pharmacology and help us transform natural compounds into life-changing medicines. We’re a team driven by curiosity and innovation - are you ready to make a difference?
Remote | Full-Time | $240,000 – $270,000
What Makes Us Enveda
Life is smart, and we can learn from it. We’re reinventing drug discovery by harnessing nature’s intelligence. Our platform identifies new medicines four times faster than the industry standard because patients can’t wait. What sets Enveda apart isn’t just what we do - it’s how we do it. Our culture is built on creativity, collaboration, and deep respect for each other. We believe “People Create All Value”, and our success is driven by the extraordinary team turning our mission into reality every day. We’re proud of the momentum we’ve built.
Our Momentum
- Unicorn status: Achieved following a $150 million Series D funding round in 2025
- Discovery and innovation: Advanced our first drug candidate to Phase 1 trials in 2024
- Award-winning culture:
- Newsweek: Top 100 Global #MostLovedWorkplaces (2025)
- Forbes: America’s Best Startup Employers (2024 & 2025)
- Newsweek: America’s Greatest Startup Workplaces (2025)
These milestones reflect the impact of our team and we’re just getting started, but they’re only possible because of the diverse talent, perspectives, and relentless drive of our team, and people like you.
Your Role in Our Mission
At Enveda, every role drives impact. As the Sr. Director, Translational Immunology and Pharmacology, you will lead the function that sits at the intersection of discovery and development - integrating mechanistic insights with clinical disease understanding to design the biomarker and translational strategies that substantiate our therapeutic hypotheses in patients. You are, above all, a communicator and translator: distilling complex, niche scientific data into what it means for our assets, clearly and compellingly, for audiences ranging from bench scientists to clinicians to senior leadership to investors. Translational Medicine tells the story of how our medicines work, and you will own that narrative.
You will be part of the ENV-294 asset team, reporting into the asset lead. At Enveda, we organize around dedicated, asset-centered teams - small, focused, and empowered groups that own every dimension of their program. We leverage AI and other force multipliers across clinical operations, medical writing, data analysis, and decision-making to stay lean and maximize impact per person. You will be expected to contribute beyond your core function, embrace an uncommon pace and breadth of responsibility, and move with urgency at every stage, without compromising quality. Speed is not a nice-to-have, it is central to how we operate and how we win. Above all, the program comes first - every decision, trade-off, and priority is measured against what best moves the program forward to best serve the portfolio.
What You’ll Do
- Lead translational immunology strategy and execution for one of our lead assets in the clinic, focusing on biomarker development, translational plans, and scientific leadership of a novel best-in-disease mechanism
- Act as a scientific bridge between discovery and clinical development teams, collaborating closely with preclinical, clinical, and operational leads
- Build and maintain strong CRO relationships that enable the rapid turnaround needed to react to clinical observations
- Translate emerging data into clear, actionable narratives for asset teams, leadership, and external audiences - with the speed and intellectual honesty the business demands
- Serve as a core member of the asset team, partnering closely with MOATID on mechanistic hypotheses, Clinical Development on protocol design, and Clinical Operations on sample collection logistics and site feasibility
We’re Looking For
- PhD, PharmD, MD or equivalent in immunology, pharmacology, translational medicine, or a related life sciences discipline
- 10+ years of translational science experience in biotech or pharma, with depth in immunology and biomarker strategy development - including designing tiered biomarker plans that link directly to program decisions and value drivers
- Exceptional ability to distill complex scientific data into clear narratives for diverse audiences - from bench scientists to clinicians to investors - and to do so with speed and intellectual honesty
- A strategic mindset that balances scientific ambition with operational pragmatism - knowing what evidence is needed, when it’s needed, and what decisions it will enable at each development stage
- Experience managing CRO relationships and external biomarker assay vendors, with a track record of enabling rapid turnaround
- Leadership experience managing teams of 5 or more in a translational or biomarker function
- A collaborative leader who thrives in a dynamic environment where our competitive advantage comes from telling novel mechanistic stories that have never been told before
If you’re passionate about innovation and impact, we encourage you to apply even if you don’t meet every requirement.
Our Values: Curiosity | Agency | Journey | Charity | Unity
Benefits: 90% Medical, Dental, Vision | 401k Match | Flexible PTO | Adoption Assistance
Enveda is protecting Job Seekers:
We care deeply about creating a safe, respectful experience for every applicant, so we wanted to share a few guidelines to help you spot anything that doesn’t feel right.
- You’ll always meet real Enveda team members through video or in-person conversations before receiving an offer.
- All communication from us will come from an @enveda.com or @envedabio.com email address.
- We’ll never ask you to purchase equipment, send money, or share sensitive banking details as part of any step in our recruiting process.
Top Skills
Enveda Biosciences Boulder, Colorado, USA Office
Boulder, CO, United States
Similar Jobs
What you need to know about the Colorado Tech Scene
Key Facts About Colorado Tech
- Number of Tech Workers: 260,000; 8.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lockheed Martin, Century Link, Comcast, BAE Systems, Level 3
- Key Industries: Software, artificial intelligence, aerospace, e-commerce, fintech, healthtech
- Funding Landscape: $4.9 billion in VC funding in 2024 (Pitchbook)
- Notable Investors: Access Venture Partners, Ridgeline Ventures, Techstars, Blackhorn Ventures
- Research Centers and Universities: Colorado School of Mines, University of Colorado Boulder, University of Denver, Colorado State University, Mesa Laboratory, Space Science Institute, National Center for Atmospheric Research, National Renewable Energy Laboratory, Gottlieb Institute
